Pluristem Therapeutics Inc

NASDAQ:PSTI   3:59:50 PM EDT
3.33
+0.05 (+1.52%)
Products

Pluristem Brings Ards Associated With Covid-19 Phase Ii Studies To Clinical Readout

Published: 07/08/2021 11:30 GMT
Pluristem Therapeutics Inc (PSTI) - Pluristem Brings Ards Associated With Covid-19 Phase Ii Studies to Clinical Readout.
Pluristem Therapeutics Inc - Company Will Analyze Data Based on Patients Enrolled to Date in Covid-19 Phase Ii Studies in U.S., Europe and Israel.
Pluristem Therapeutics Inc - Topline Results Are Expected During Q4 of 2021.
Pluristem Therapeutics - Will Not Pursue Plans Announced in Dec.
2020 to Expand Covid-19 Program to Mexico in Collaboration With Innovare Research and Development.